SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-24-039683
Filing Date
2024-09-06
Accepted
2024-09-06 16:06:29
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-3 spyretherapeutics-sx3shelf.htm S-3 392082
2 EX-FILING FEES exhibit107-sx3shelf.htm EX-FILING FEES 39094
3 EX-1.2 exhibit12-sx3shelf.htm EX-1.2 298321
4 EX-4.2 exhibit42-sx3shelf.htm EX-4.2 448493
5 EX-5.1 exhibit51-sx3shelf.htm EX-5.1 41149
6 EX-5.2 exhibit52-sx3shelf.htm EX-5.2 7323
7 EX-23.1 exhibit231-sx3shelf.htm EX-23.1 3463
8 EX-23.2 exhibit232-sx3shelf.htm EX-23.2 2357
9 backcover.jpg GRAPHIC 5237
10 companylogo.jpg GRAPHIC 79208
11 image_1.jpg GRAPHIC 79120
12 prospectuscover1aa.jpg GRAPHIC 27568
  Complete submission text file 0001628280-24-039683.txt   1496979
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-281975 | Film No.: 241284548
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)